TY - JOUR
T1 - Mineral metabolism in European children living with a renal transplant
T2 - A European society for paediatric nephrology/European renal association–european dialysis and transplant association registry study
AU - Bonthuis, Marjolein
AU - Busutti, Marco
AU - van Stralen, Karlijn J.
AU - Jager, Kitty J.
AU - Baiko, Sergey
AU - Bakkaloğlu, Sevcan
AU - Battelino, Nina
AU - Gaydarova, Maria
AU - Gianoglio, Bruno
AU - Parvex, Paloma
AU - Gomes, Clara
AU - Heaf, James G.
AU - Podracka, Ludmila
AU - Kuzmanovska, Dafina
AU - Molchanova, Maria S.
AU - Pankratenko, Tatiana E.
AU - Papachristou, Fotios
AU - Reusz, György
AU - Sanahuja, Maria Josè
AU - Shroff, Rukshana
AU - Groothoff, Jaap W.
AU - Schaefer, Franz
AU - Verrina, Enrico
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Background and objectives Data on mineral metabolism in pediatric renal transplant recipients largely arise from small single-center studies. In adult patients, abnormal mineral levels are related to a higher risk of graft failure. This study used data from the European Society for Paediatric Nephrology/European Renal Association– European Dialysis and Transplant Association Registry to study the prevalence and potential determinants of mineral abnormalities, as well as the predictive value of a disturbed mineral level on graft survival in a large cohort of European pediatric renal transplant recipients. Design, setting, participants, & measurements This study included 1237 children (0–17 years) from 10 European countries, who had serum calcium, phosphorus, and parathyroid hormone measurements from 2000 onward. Abnormalities of mineral metabolism were defined according to European guidelines on prevention and treatment of renal osteodystrophy in children on chronic renal failure. Results Abnormal serum phosphorus levels were observed in 25% (14% hypophosphatemia and 11% hyperphosphatemia), altered serum calcium in 30% (19% hypocalcemia, 11% hypercalcemia), and hyperparathyroidism in 41% of the patients. A longer time since transplantation was associated with a lower risk of having mineral levels above target range. Serum phosphorus levels were inversely associated with eGFR, and levels above the recommended targets were associated with a higher risk of graft failure independently of eGFR. Conclusions Abnormalities in mineral metabolism are common after pediatric renal transplantation in Europe and are associated with graft dysfunction.
AB - Background and objectives Data on mineral metabolism in pediatric renal transplant recipients largely arise from small single-center studies. In adult patients, abnormal mineral levels are related to a higher risk of graft failure. This study used data from the European Society for Paediatric Nephrology/European Renal Association– European Dialysis and Transplant Association Registry to study the prevalence and potential determinants of mineral abnormalities, as well as the predictive value of a disturbed mineral level on graft survival in a large cohort of European pediatric renal transplant recipients. Design, setting, participants, & measurements This study included 1237 children (0–17 years) from 10 European countries, who had serum calcium, phosphorus, and parathyroid hormone measurements from 2000 onward. Abnormalities of mineral metabolism were defined according to European guidelines on prevention and treatment of renal osteodystrophy in children on chronic renal failure. Results Abnormal serum phosphorus levels were observed in 25% (14% hypophosphatemia and 11% hyperphosphatemia), altered serum calcium in 30% (19% hypocalcemia, 11% hypercalcemia), and hyperparathyroidism in 41% of the patients. A longer time since transplantation was associated with a lower risk of having mineral levels above target range. Serum phosphorus levels were inversely associated with eGFR, and levels above the recommended targets were associated with a higher risk of graft failure independently of eGFR. Conclusions Abnormalities in mineral metabolism are common after pediatric renal transplantation in Europe and are associated with graft dysfunction.
UR - http://www.scopus.com/inward/record.url?scp=84929179514&partnerID=8YFLogxK
U2 - 10.2215/CJN.06200614
DO - 10.2215/CJN.06200614
M3 - Article
C2 - 25710805
AN - SCOPUS:84929179514
SN - 1555-9041
VL - 10
SP - 767
EP - 775
JO - Clinical Journal of the American Society of Nephrology
JF - Clinical Journal of the American Society of Nephrology
IS - 5
ER -